Neuroimmune endocrine effects of antidepressants

References

• KesslerRCEpidemiology of women and depressionJ Affect Disord200374151312646294
   PubMed Web of Science ®Google Scholar
• O’BrienSMScottLVDinanTGCytokines: abnormalities in major depression and implications for pharmacological treatmentHum Psychopharmacol200419639740315303243
   PubMed Web of Science ®Google Scholar
• GermainAKupferDJCircadian rhythm disturbances in depressionHum Psychopharmacol200823757158518680211
   PubMed Web of Science ®Google Scholar
• CarvalhoLAParianteCMIn vitro modulation of the glucocorticoid receptor by antidepressantsStress200811641142419065455
   PubMed Web of Science ®Google Scholar
• LeeSJeongJKwakYParkSKDepression research: where are we nowMol Brain20103820219105
   PubMed Web of Science ®Google Scholar
• ZunszainPAAnackerCCattaneoACarvalhoLAParianteCMGlucocorticoids, cytokines and brain abnormalities in depressionProg Neuropsychopharmacol Biol Psychiatry201135372277920406665
   PubMed Web of Science ®Google Scholar
• AnackerCZunszainPACarvalhoLAParianteCMThe glucocorticoid receptor: pivot of depression and of antidepressant treatment?Psychoneuroendocrinology201136341542520399565
   PubMed Web of Science ®Google Scholar
• AxelrodJWurtmanRJSnyderSHControl of hydroxyindole O-methyltransferase activity in the rat pineal gland by environmental lightingJ Biol Chem196524094995414275158
   PubMed Web of Science ®Google Scholar
• HardelandRMelatonin: signaling mechanisms of a pleiotropic agentBiofactors200935218319219449447
   PubMed Web of Science ®Google Scholar
• MarondeEStehleJHThe mammalian pineal gland: known facts, unknown facetsTrends Endocrinol Metab200718414214917374488
   PubMed Web of Science ®Google Scholar
• HankinsMWLucasRJThe primary visual pathway in humans is regulated according to long-term light exposure through the action of a nonclassical photopigmentCurr Biol200212319119811839270
   PubMed Web of Science ®Google Scholar
• BrainardGCSlineyDHanifinJPSensitivity of the human circadian system to short-wavelength (420-nm) lightJ Biol Rhythms200823537938618838601
   PubMed Web of Science ®Google Scholar
• JasserSABlaskDEBrainardGCLight during darkness and cancer: relationships in circadian photoreception and tumor biologyCancer Causes Control200617451552316596305
   PubMed Web of Science ®Google Scholar
• DeurveilherSSembaKIndirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural stateNeuroscience2005130116518315561433
   PubMed Web of Science ®Google Scholar
• LeanderPVrangNMollerMNeuronal projections from the mesencephalic raphe nuclear complex to the suprachiasmatic nucleus and the deep pineal gland of the golden hamster (Mesocricetus auratus)J Comp Neurol1998399173939725702
   PubMed Web of Science ®Google Scholar
• YingSWRusakBEffects of serotonergic agonists on firing rates of photically responsive cells in the hamster suprachiasmatic nucleusBrain Res19946511–237467922588
   PubMed Web of Science ®Google Scholar
• QuinteroJEMcMahonDGSerotonin modulates glutamate responses in isolated suprachiasmatic nucleus neuronsJ Neurophysiol199982253353910444653
   PubMed Web of Science ®Google Scholar
• ReiterRJTanDXFuentes-BrotoLMelatonin: a multitasking moleculeProg Brain Res201018112715120478436
   PubMed Web of Science ®Google Scholar
• CowenPJGreenARGrahame-SmithDGBraddockLEPlasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmissionBr J Clin Pharmacol19851967998052992560
   PubMed Web of Science ®Google Scholar
• PalazidouEPapadopoulosARatcliffHDawlingSCheckleySANoradrenaline uptake inhibition increases melatonin secretion, a measure of noradrenergic neurotransmission, in depressed patientsPsychol Med19922223093151319597
   PubMed Web of Science ®Google Scholar
• SugdenDComparison of circadian expression of tryptophan hydroxylase isoform mRNAs in the rat pineal gland using real-time PCRJ Neurochem20038651308131112911638
   PubMed Web of Science ®Google Scholar
• AgezLLaurentVGuerreroHYPevetPMasson-PevetMGauerFEndogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the ratJ Pineal Res20094619510519090912
   PubMed Web of Science ®Google Scholar
• SotthibundhuAPhansuwan-PujitoPGovitrapongPMelatonin increases proliferation of cultured neural stem cells obtained from adult mouse subventricular zoneJ Pineal Res201049329130020663047
   PubMed Web of Science ®Google Scholar
• SrinivasanVSpenceDWTrakhtIPandi-PerumalSRCardinaliDPMaestroniGJImmunomodulation by melatonin: its significance for seasonally occurring diseasesNeuroimmunomodulation20081529310118679047
   PubMed Web of Science ®Google Scholar
• MaldonadoMDMurillo-CabezasFCalvoJRMelatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damageCrit Care Med20073541177118517312564
   PubMed Web of Science ®Google Scholar
• MaldonadoMDMurillo-CabezasFTerronMPThe potential of melatonin in reducing morbidity-mortality after craniocerebral traumaJ Pineal Res200742111117198533
   PubMed Web of Science ®Google Scholar
• CernysiovVGerasimcikNMauricasMGirkontaiteIRegulation of T-cell-independent and T-cell-dependent antibody production by circadian rhythm and melatoninInt Immunol2010221253419946015
   PubMed Web of Science ®Google Scholar
• AgilARosadoIRuizRFigueroaAZenNFernandez-VazquezGMelatonin improves glucose homeostasis in young Zucker diabetic fatty ratsJ Pineal ResJuly 262011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Sanchez-HidalgoMLuZTanDXMaldonadoMDReiterRJGregermanRIMelatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosisAm J Physiol Regul Integr Comp Physiol20072926R2208221517379847
   PubMed Web of Science ®Google Scholar
• ReiterRJTanDXLeonJKilicUKilicEWhen melatonin gets on your nerves: its beneficial actions in experimental models of strokeExp Biol Med (Maywood)2005230210411715673559
   PubMed Web of Science ®Google Scholar
• TanDXManchesterLCTerronMPFloresLJReiterRJOne molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?J Pineal Res2007421284217198536
   PubMed Web of Science ®Google Scholar
• Garcia-NavarroAGonzalez-PugaCEscamesGCellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in cultureJ Pineal Res200743219520517645698
   PubMed Web of Science ®Google Scholar
• ParryBLMeliskaCJSorensonDLPlasma melatonin circadian rhythm disturbances during pregnancy and postpartum in depressed women and women with personal or family histories of depressionAm J Psychiatry2008165121551155818829869
   PubMed Web of Science ®Google Scholar
• Beck-FriisJKjellmanBFAperiaBSerum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndromeActa Psychiatr Scand19857143193304039876
   PubMed Web of Science ®Google Scholar
• PaparrigopoulosTMelatonin response to atenolol administration in depression: indication of beta-adrenoceptor dysfunction in a subtype of depressionActa Psychiatr Scand2002106644044512392487
   PubMed Web of Science ®Google Scholar
• Beck-FriisJLjunggrenJGThorenMvonRDKjellmanBFWetterbergLMelatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression testPsychoneuroendocrinology19851021731862994141
   PubMed Web of Science ®Google Scholar
• ParryBLMeliskaCJSorensonDLIncreased melatonin and delayed offset in menopausal depression: role of years past menopause, follicle-stimulating hormone, sleep end time, and body mass indexJ Clin Endocrinol Metab2008931546018042653
   PubMed Web of Science ®Google Scholar
• BrownRKocsisJHCaroffSDifferences in nocturnal melatonin secretion between melancholic depressed patients and control subjectsAm J Psychiatry198514278118164014502
   PubMed Web of Science ®Google Scholar
• FountoulakisKNKaramouzisMIacovidesAMorning and evening plasma melatonin and dexamethasone suppression test in patients with nonseasonal major depressive disorder from northern Greece (latitude 40–41.5 degrees)Neuropsychobiology200144311311711586048
   PubMed Web of Science ®Google Scholar
• TuunainenAKripkeDFElliottJADepression and endogenous melatonin in postmenopausal womenJ Affect Disord2002691–314915812103461
   PubMed Web of Science ®Google Scholar
• DetanicoBCPiatoALFreitasJJAntidepressant-like effects of melatonin in the mouse chronic mild stress modelEur J Pharmacol20096071–312112519249298
   PubMed Web of Science ®Google Scholar
• WeilZMHotchkissAKGatienMLPieke-DahlSNelsonRJMelatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gatingBrain Res Bull200668642542916459197
   PubMed Web of Science ®Google Scholar
• WuYHZhouJNBalesarRDistribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin- releasing hormoneJ Comp Neurol2006499689791017072839
   PubMed Web of Science ®Google Scholar
• RosenwasserAMFunctional neuroanatomy of sleep and circadian rhythmsBrain Res Rev200961228130619695288
   PubMedGoogle Scholar
• GaleckiPSzemrajJBartoszGSingle-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorderJ Pineal Res201048431131720433639
   PubMed Web of Science ®Google Scholar
• BoycePBarriballECircadian rhythms and depressionAust Fam Physician201039530731020485718
   PubMed Web of Science ®Google Scholar
• LamRWLevitanRDPathophysiology of seasonal affective disorder: a reviewJ Psychiatry Neurosci200025546948011109298
   PubMed Web of Science ®Google Scholar
• GoldenRNGaynesBNEkstromRDThe efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidenceAm J Psychiatry2005162465666215800134
   PubMed Web of Science ®Google Scholar
• OkamuraHSuprachiasmatic nucleus clock time in the mammalian circadian systemCold Spring Harb Symp Quant Biol20077255155618419314
   PubMedGoogle Scholar
• PilorzVSteinlechnerSOsterHAge and oestrus cycle-related changes in glucocorticoid excretion and wheel-running activity in female mice carrying mutations in the circadian clock genes Per1 and Per2Physiol Behav2009961576318786554
   PubMed Web of Science ®Google Scholar
• LinkowskiPVan CauterELeclercqRACTH, cortisol and growth hormone 24-hour profiles in major depressive illnessActa Psychiatr Belg19858556156233004110
   PubMedGoogle Scholar
• SouetreESalvatiEBelugouJLCircadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormalityPsychiatry Res19892832632782762432
   PubMed Web of Science ®Google Scholar
• CampinoCValenzuelaFJTorres-FarfanCMelatonin exerts direct inhibitory actions on ACTH responses in the human adrenal glandHorm Metab Res201143533734221332028
   PubMed Web of Science ®Google Scholar
• EmensJLewyAKinzieJMArntzDRoughJCircadian misalignment in major depressive disorderPsychiatry Res2009168325926119524304
   PubMed Web of Science ®Google Scholar
• HaslerBPBuysseDJKupferDJGermainAPhase relationships between core body temperature, melatonin, and sleep are associated with depression severity: further evidence for circadian misalignment in non-seasonal depressionPsychiatry Res2010178120520720471106
   PubMed Web of Science ®Google Scholar
• BuckleyTMSchatzbergAFA pilot study of the phase angle between cortisol and melatonin in major depression – a potential biomarker?J Psychiatr Res2010442697420004915
   PubMed Web of Science ®Google Scholar
• ParianteCMGlucocorticoid receptor function in vitro in patients with major depressionStress20047420921916019586
   PubMed Web of Science ®Google Scholar
• HerbertJGoodyerIMGrossmanABDo corticosteroids damage the brain?J Neuroendocrinol200618639341116684130
   PubMed Web of Science ®Google Scholar
• de KloetERVreugdenhilEOitzlMSJoelsMBrain corticosteroid receptor balance in health and diseaseEndocr Rev19981932693019626555
   PubMed Web of Science ®Google Scholar
• TaskerJGDiSMalcher-LopesRMinireview: rapid glucocorticoid signaling via membrane-associated receptorsEndocrinology2006147125549555616946006
   PubMed Web of Science ®Google Scholar
• de KloetERDerijkRHMeijerOCTherapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?Nat Clin Pract Endocrinol Metab20073216817917237843
   PubMedGoogle Scholar
• NavarraPTsagarakisSFariaMSReesLHBesserGMGrossmanABInterleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathwayEndocrinology1991128137441846105
   PubMed Web of Science ®Google Scholar
• KaralisKMugliaLJBaeDHilderbrandHMajzoubJACRH and the immune systemJ Neuroimmunol19977221311369042104
   PubMed Web of Science ®Google Scholar
• ZhouDKusnecovAWShurinMRDePaoliMRabinBSExposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axisEndocrinology19931336252325308243274
   PubMed Web of Science ®Google Scholar
• HolsboerFThe corticosteroid receptor hypothesis of depressionNeuropsychopharmacology200023547750111027914
   PubMed Web of Science ®Google Scholar
• McQuadeRYoungAHFuture therapeutic targets in mood disorders: the glucocorticoid receptorBr J Psychiatry200017739039511059990
   PubMed Web of Science ®Google Scholar
• HeuserIYassouridisAHolsboerFThe combined dexamethasone/CRH test: a refined laboratory test for psychiatric disordersJ Psychiatr Res19942843413567877114
   PubMed Web of Science ®Google Scholar
• NemeroffCBThe corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directionsMol Psychiatry1996143363429118360
   PubMed Web of Science ®Google Scholar
• ParianteCMMillerAHGlucocorticoid receptors in major depression: relevance to pathophysiology and treatmentBiol Psychiatry200149539140411274650
   PubMed Web of Science ®Google Scholar
• GoldPWGoodwinFKChrousosGPClinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)N Engl J Med198831963483533292920
   PubMed Web of Science ®Google Scholar
• CarrollBJFeinbergMGredenJFA specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utilityArch Gen Psychiatry198138115227458567
   PubMed Web of Science ®Google Scholar
• AxelsonDADoraiswamyPMBoykoOBIn vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patientsPsychiatry Res199244163701461948
   PubMed Web of Science ®Google Scholar
• RubinRDinanTJScottLVThe neuroendocrinology of affective disordersPfaffDArnoldAPEtgenAMFahrbachSEMossPLRubinRTHormones, Brain and BehaviourNew York, NYNew York Academic Press2001
   Google Scholar
• KunugiHIdaIOwashiTKimuraMAssessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic- pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter studyNeuropsychopharmacology200631121222016123748
   PubMed Web of Science ®Google Scholar
• YoungEAHaskettRFMurphy-WeinbergVWatsonSJAkilHLoss of glucocorticoid fast feedback in depressionArch Gen Psychiatry19914886936991652926
   PubMed Web of Science ®Google Scholar
• CooneyJMDinanTGPreservation of hypothalamic-pituitary-adrenal axis fast-feedback responses in depressionActa Psychiatr Scand19969464494539020998
   PubMed Web of Science ®Google Scholar
• LinkowskiPMendlewiczJKerkhofsM24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatmentJ Clin Endocrinol Metab19876511411523034952
   PubMed Web of Science ®Google Scholar
• HeuserIJSchweigerUGotthardtUPituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjectsAm J Psychiatry1996153193998540599
   PubMed Web of Science ®Google Scholar
• BhagwagarZHafiziSCowenPJIncrease in concentration of waking salivary cortisol in recovered patients with depressionAm J Psychiatry2003160101890189114514508
   PubMed Web of Science ®Google Scholar
• TuomistoJMannistoPNeurotransmitter regulation of anterior pituitary hormonesPharmacol Rev19853732493322869509
   PubMed Web of Science ®Google Scholar
• PlotskyPMCunninghamETJrWidmaierEPCatecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretionEndocr Rev19891044374582558876
   PubMed Web of Science ®Google Scholar
• WurtmanRJAltschuleMdHolmgrenUEffects of pinealectomy and of a bovine pineal extract in ratsAm J Physiol1959197110811013661402
   PubMed Web of Science ®Google Scholar
• KonakchievaRMitevYAlmeidaOFPatchevVKChronic melatonin treatment and the hypothalamo-pituitary-adrenal axis in the rat: attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and releaseBiol Cell19978995875969673011
   PubMed Web of Science ®Google Scholar
• KonakchievaRMitevYAlmeidaOFPatchevVKChronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis in the ratNeuroendocrinology19986731711809630434
   PubMed Web of Science ®Google Scholar
• BardenNShinkELabbeMVacherRRochfordJMocaerEAntidepressant action of agomelatine (S20098) in a transgenic mouse modelProg Neuropsychopharmacol Biol Psychiatry200529690891616005135
   PubMed Web of Science ®Google Scholar
• PresmanDMHoijmanECeballosNRGalignianaMDPecciAMelatonin inhibits glucocorticoid receptor nuclear translocation in mouse thymocytesEndocrinology2006147115452545916916958
   PubMed Web of Science ®Google Scholar
• FernandesPABothorelBClesseDLocal corticosterone infusion enhances nocturnal pineal melatonin production in vivoJ Neuroendocrinol2009212909719076264
   PubMed Web of Science ®Google Scholar
• Couto-MoraesRPalermo-NetoJMarkusRPThe immune-pineal axis: stress as a modulator of pineal gland functionAnn N Y Acad Sci2009115319320219236342
   PubMed Web of Science ®Google Scholar
• FerreiraZSFernandesPADumaDAssreuyJAvellarMCMarkusRPCorticosterone modulates noradrenaline-induced melatonin synthesis through inhibition of nuclear factor kappa BJ Pineal Res200538318218815725340
   PubMed Web of Science ®Google Scholar
• FischerSSmolnikRHermsMBornJFehmHLMelatonin acutely improves the neuroendocrine architecture of sleep in blind individualsJ Clin Endocrinol Metab200388115315532014602767
   PubMed Web of Science ®Google Scholar
• BrietzkeEStertzLFernandesBSComparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorderJ Affect Disord2009116321421719251324
   PubMed Web of Science ®Google Scholar
• JehnCFKuhnhardtDBartholomaeAAssociation of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancerIntegr Cancer Ther20109327027520702499
   PubMed Web of Science ®Google Scholar
• AlesciSMartinezPEKelkarSMajor depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implicationsJ Clin Endocrinol Metab20059052522253015705924
   PubMed Web of Science ®Google Scholar
• BouhuysALFlentgeFOldehinkelAJvan den BergMDPotential psychosocial mechanisms linking depression to immune function in elderly subjectsPsychiatry Res2004127323724515296823
   PubMed Web of Science ®Google Scholar
• TiemeierHHofmanAvan TuijlHRKiliaanAJMeijerJBretelerMMInflammatory proteins and depression in the elderlyEpidemiology200314110310712500057
   PubMed Web of Science ®Google Scholar
• LanquillonSKriegJCBening-Abu-ShachUVedderHCytokine production and treatment response in major depressive disorderNeuropsychopharmacology200022437037910700656
   PubMed Web of Science ®Google Scholar
• MikovaOYakimovaRBosmansEKenisGMaesMIncreased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosisEur Neuropsychopharmacol200111320320811418279
   PubMed Web of Science ®Google Scholar
• TugluCKaraSHCaliyurtOVardarEAbayEIncreased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorderPsychopharmacology (Berl)2003170442943312955291
   PubMed Web of Science ®Google Scholar
• OwenBMEcclestonDFerrierINYoungAHRaised levels of plasma interleukin-1beta in major and postviral depressionActa Psychiatr Scand2001103322622811240580
   PubMed Web of Science ®Google Scholar
• FordDEErlingerTPDepression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination SurveyArch Intern Med200416491010101415136311
   PubMedGoogle Scholar
• DannerMKaslSVAbramsonJLVaccarinoVAssociation between depression and elevated C-reactive proteinPsychosom Med200365334735612764206
   PubMed Web of Science ®Google Scholar
• ThomasAJDavisSMorrisCJacksonEHarrisonRO’BrienJTIncrease in interleukin-1beta in late-life depressionAm J Psychiatry2005162117517715625217
   PubMed Web of Science ®Google Scholar
• YuYWChenTJHongCJChenHMTsaiSJAssociation study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant responseNeuropsychopharmacology20032861182118512700687
   PubMed Web of Science ®Google Scholar
• JunTYPaeCUHoonHPossible association between G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean populationPsychiatr Genet200313317918112960751
   PubMed Web of Science ®Google Scholar
• CapuronLMillerAHCytokines and psychopathology: lessons from interferon-alphaBiol Psychiatry2004561181982415576057
   PubMed Web of Science ®Google Scholar
• ParianteCMPearceBDPisellTLThe proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and functionEndocrinology199914094359436610465310
   PubMed Web of Science ®Google Scholar
• OrruMGBaitaASitziaRInterferon-alpha-induced psychiatric side effects in patients with chronic viral hepatitis: a prospective, observational, controlled studyEpidemiol Psichiatr Soc2005143145153 Italian16255161
   PubMedGoogle Scholar
• MusselmanDLLawsonDHGumnickJFParoxetine for the prevention of depression induced by high-dose interferon alfaN Engl J Med20013441396196611274622
   PubMed Web of Science ®Google Scholar
• HuangYHenryCJDantzerRJohnsonRWGodboutJPExaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharideNeurobiol Aging200829111744175317543422
   PubMed Web of Science ®Google Scholar
• PaceTWHuFMillerAHCytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depressionBrain Behav Immun200721191917070667
   PubMed Web of Science ®Google Scholar
• HaddadJJSaadeNESafieh-GarabedianBCytokines and neuroimmune- endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axisJ Neuroimmunol20021331–211912446003
   PubMed Web of Science ®Google Scholar
• Spath-SchwalbeEHansenKSchmidtFAcute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy menJ Clin Endocrinol Metab1998835157315799589658
   PubMed Web of Science ®Google Scholar
• MaddockCParianteCMHow does stress affect you? An overview of stress, immunity, depression and diseaseEpidemiol Psichiatr Soc2001103153162 Italian11787449
   PubMedGoogle Scholar
• ParianteCMPearceBDPisellTLOwensMJMillerAHSteroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramineMol Pharmacol19975245715819380019
   PubMed Web of Science ®Google Scholar
• WangXWuHMillerAHInterleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor functionMol Psychiatry200491657514699442
   PubMed Web of Science ®Google Scholar
• PierpaoliWNeuroimmunomodulation of aging. A program in the pineal glandAnn N Y Acad Sci19988404914979629275
   PubMed Web of Science ®Google Scholar
• Skwarlo-SontaKMajewskiPMarkowskaMOblapROlszanskaBBidirectional communication between the pineal gland and the immune systemCan J Physiol Pharmacol200381434234912769226
   PubMed Web of Science ®Google Scholar
• da Silveira Cruz-MachadoSCarvalho-SousaCETamuraEKTLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathwayJ Pineal Res201049218319220586888
   PubMed Web of Science ®Google Scholar
• BrancheyLWeinbergUBrancheyMLinkowskiPMendlewiczJSimultaneous study of 24-hour patterns of melatonin and cortisol secretion in depressed patientsNeuropsychobiology1982852252327133371
   PubMed Web of Science ®Google Scholar
• BlomekeBGolkaKGriefahnBRoemerHCArylalkylamine N-acetyltransferase (AANAT) genotype as a personal trait in melatonin synthesisJ Toxicol Environ Health A20087113–1487487618569588
   PubMed Web of Science ®Google Scholar
• CardinaliDPVacasMIKeller SarmientoMIEtchegoyenGSPereyraENChuluyanHENeuroendocrine integrative mechanisms in mammalian pineal gland: effects of steroid and adenohypophyseal hormones on melatonin synthesis in vitroJ Steroid Biochem1987271–35655712447392
   PubMedGoogle Scholar
• MurrayDRPrabhuSDChandrasekarBChronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expressionCirculation2000101202338234110821806
   PubMed Web of Science ®Google Scholar
• SchauensteinKFelsnerPRinnerIIn vivo immunomodulation by peripheral adrenergic and cholinergic agonists/antagonists in rat and mouse modelsAnn N Y Acad Sci200091761862711268390
   PubMed Web of Science ®Google Scholar
• MayerBHolmerSRHengstenbergCLiebWPfeiferMSchunkertHFunctional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levelsInt J Cardiol2005103218218616080978
   PubMed Web of Science ®Google Scholar
• BierhausAWolfJAndrassyMA mechanism converting psychosocial stress into mononuclear cell activationProc Natl Acad Sci U S A200310041920192512578963
   PubMed Web of Science ®Google Scholar
• MaestroniGJContiAPierpaoliWRole of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosteroneJ Neuroimmunol198613119302944914
   PubMed Web of Science ®Google Scholar
• ChuangJIMohanNMeltzMLReiterRJEffect of melatonin on NF-kappa-B DNA-binding activity in the rat spleenCell Biol Int199620106876928969462
   PubMed Web of Science ®Google Scholar
• MohanNSadeghiKReiterRJMeltzMLThe neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa BBiochem Mol Biol Int1995376106310708747536
   PubMedGoogle Scholar
• CristofanonSUguccioniFCerellaCIntracellular prooxidant activity of melatonin induces a survival pathway involving NF-kappaB activationAnn N Y Acad Sci2009117147247819723091
   PubMed Web of Science ®Google Scholar
• CeconEFernandesPAPinatoLFerreiraZSMarkusRPDaily variation of constitutively activated nuclear factor kappa B (NFKB) in rat pineal glandChronobiol Int2010271526720205557
   PubMed Web of Science ®Google Scholar
• JinWWangHYanWDisruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injuryMediators Inflamm2008200872517419190763
   PubMed Web of Science ®Google Scholar
• ThimmulappaRKLeeHRangasamyTNrf2 is a critical regulator of the innate immune response and survival during experimental sepsisJ Clin Invest2006116498499516585964
   PubMed Web of Science ®Google Scholar
• SmoakKACidlowskiJAMechanisms of glucocorticoid receptor signaling during inflammationMech Ageing Dev200412510–1169770615541765
   PubMed Web of Science ®Google Scholar
• MillerMAKandalaNBKivimakiMGender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II studySleep200932785786419639748
   PubMed Web of Science ®Google Scholar
• Carrillo-VicoAGuerreroJMLardonePJReiterRJA review of the multiple actions of melatonin on the immune systemEndocrine200527218920016217132
   PubMed Web of Science ®Google Scholar
• RadognaFDiederichMGhibelliLMelatonin: a pleiotropic molecule regulating inflammationBiochem Pharmacol201080121844185220696138
   PubMed Web of Science ®Google Scholar
• Skwarlo-SontaKMelatonin in immunity: comparative aspectsNeuro Endocrinol Lett200223Suppl 1616612019354
   PubMed Web of Science ®Google Scholar
• WichersMCMaesMThe role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depressionJ Psychiatry Neurosci2004291111714719046
   PubMed Web of Science ®Google Scholar
• WichersMCKoekGHRobaeysGVerkerkRScharpeSMaesMIDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicityMol Psychiatry200510653854415494706
   PubMed Web of Science ®Google Scholar
• MullerNSchwarzMJThe immune-mediated alteration of serotonin and glutamate: towards an integrated view of depressionMol Psychiatry20071211988100017457312
   PubMed Web of Science ®Google Scholar
• MaesMYirmyiaRNorabergJThe inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depressionMetab Brain Dis2009241275319085093
   PubMed Web of Science ®Google Scholar
• O’ConnorJCLawsonMAAndreCLipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in miceMol Psychiatry200914551152218195714
   PubMed Web of Science ®Google Scholar
• RacagniGPopoliMThe pharmacological properties of antidepressantsInt Clin Psychopharmacol201025311713120305568
   PubMed Web of Science ®Google Scholar
• ParfittAKleinDCIncrease caused by desmethylimipramine in the production of [3H]melatonin by isolated pineal glandsBiochem Pharmacol1977269904905861059
   PubMed Web of Science ®Google Scholar
• CowenPJFraserSGrahame-SmithDGGreenARStanfordCThe effect of chronic antidepressant administration on beta-adrenoceptor function of the rat pinealBr J Pharmacol198378189966130811
   PubMed Web of Science ®Google Scholar
• FranklinMClementEMCamplingGCowenPJEffect of venlafaxine on pineal melatonin and noradrenaline in the male ratJ Psychopharmacol199812437137410065911
   PubMed Web of Science ®Google Scholar
• UzTAhmedRAkhisarogluMEffect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatumNeuroscience200513441309131615994025
   PubMed Web of Science ®Google Scholar
• PastrakuljicATangBKRobertsEAKalowWDistinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafroleBiochem Pharmacol19975345315389105404
   PubMed Web of Science ®Google Scholar
• HartterSWangXWeigmannHDifferential effects of fluvoxamine and other antidepressants on the biotransformation of melatoninJ Clin Psychopharmacol200121216717411270913
   PubMed Web of Science ®Google Scholar
• BadawyAAMorganCJEffects of acute paroxetine administration on tryptophan metabolism and disposition in the ratBr J Pharmacol199110224294331826617
   PubMed Web of Science ®Google Scholar
• BearnJFraneyCArendtJCheckleySAA study of the effects of desipramine treatment alone and in combination with L-triiodothyronine on 6-sulphatoxymelatonin excretion in depressed patientsBr J Psychiatry19891553413472611544
   PubMed Web of Science ®Google Scholar
• KennedySHBrownGMEffect of chronic antidepressant treatment with adinazolam and desipramine on melatonin outputPsychiatry Res19924321771851410073
   PubMed Web of Science ®Google Scholar
• ThompsonCMezeyGCornTThe effect of desipramine upon melatonin and cortisol secretion in depressed and normal subjectsBr J Psychiatry19851473893934075027
   PubMed Web of Science ®Google Scholar
• GoldenRNMarkeySPRisbyEDRudorferMVCowdryRWPotterWZAntidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin outputArch Gen Psychiatry19884521501543122700
   PubMed Web of Science ®Google Scholar
• SchmidDAWichniakAUhrMChanges of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEXCRH test in depressed patients during treatment with mirtazapineNeuropsychopharmacology200631483284416237393
   PubMed Web of Science ®Google Scholar
• CarvalhoLGorensteinCMorenoRParianteCMarkusREffect of antidepressants on melatonin metabolite in depressed patientsJ Psychopharmacol200923331532118562432
   PubMed Web of Science ®Google Scholar
• Rabe-JablonskaJSzymanskaADiurnal profile of melatonin secretion in the acute phase of major depression and in remissionMed Sci Monit20017594695211535940
   PubMedGoogle Scholar
• MillerHLEkstromRDMasonGALydiardRBGoldenRNNoradrenergic function and clinical outcome in antidepressant pharmacotherapyNeuropsychopharmacology200124661762311331141
   PubMed Web of Science ®Google Scholar
• FraneyCAldhousMBurtonSCheckleySArendtJAcute treatment with desipramine stimulates melatonin and 6-sulphatoxy melatonin production in manBr J Clin Pharmacol198622173793741729
   PubMed Web of Science ®Google Scholar
• DemischKDemischLBochnikHJMelatonin and cortisol increase after fluvoxamineBr J Clin Pharmacol19862256206223098271
   PubMed Web of Science ®Google Scholar
• PalazidouESkeneDArendtJEverittBCheckleySAThe acute and chronic effects of (+) and (−) oxaprotiline upon melatonin secretion in normal subjectsPsychol Med199222161671315445
   PubMed Web of Science ®Google Scholar
• PalazidouEPapadopoulosASitsenAStahlSCheckleySAn alpha 2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in manPsychopharmacology (Berl)19899711151172565588
   PubMed Web of Science ®Google Scholar
• MarkusRPFrancoDGCarvalhoLAGentilVGorensteinCAcute increase in urinary 6-sulfatoximelatonin after clomipramine, as a predictive measure for emotional improvementJ Psychopharmacol201024685586019264813
   PubMed Web of Science ®Google Scholar
• DemischKDemischLNickelsenTRiethRThe influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamineJ Neural Transm1987683–42572703104537
   PubMed Web of Science ®Google Scholar
• SkeneDJBojkowskiCJArendtJComparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humansBr J Clin Pharmacol19943721811868186063
   PubMed Web of Science ®Google Scholar
• CeladaPPerezJAlvarezEArtigasFMonoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvementJ Clin Psychopharmacol19921253093151282522
   PubMed Web of Science ®Google Scholar
• ZolkowskaDRothmanRBBaumannMHAmphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary diseaseJ Pharmacol Exp Ther2006318260461016644904
   PubMed Web of Science ®Google Scholar
• ChildsPARodinIMartinNJEffect of fluoxetine on melatonin in patients with seasonal affective disorder and matched controlsBr J Psychiatry199516621961987728363
   PubMed Web of Science ®Google Scholar
• NathanPJNormanTRBurrowsGDNocturnal plasma melatonin concentrations in healthy volunteers: effect of single doses of d-fenfluramine, paroxetine, and ipsapironeJ Pineal Res199621255588912230
   PubMed Web of Science ®Google Scholar
• TanZLBaoAMZhaoGQLiuYJZhouJNEffect of fluoxetine on circadian rhythm of melatonin in patients with major depressive disorderNeuro Endocrinol Lett2007281283217277729
   PubMed Web of Science ®Google Scholar
• CuestaMMendozaJClesseDPevetPChalletESerotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodentExp Neurol2008210250151318190911
   PubMed Web of Science ®Google Scholar
• SprouseJBraseltonJReynoldsLFluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firingBiol Psychiatry200660889689916631132
   PubMed Web of Science ®Google Scholar
• PeifferAVeilleuxSBardenNAntidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brainPsychoneuroendocrinology19911665055151811246
   PubMed Web of Science ®Google Scholar
• ParianteCMMakoffALovestoneSAntidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transportersBr J Pharmacol200113461335134311704655
   PubMed Web of Science ®Google Scholar
• OkugawaGOmoriKSuzukawaJFujisekiYKinoshitaTInagakiCLong-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neuronesJ Neuroendocrinol1999111188789510520140
   PubMed Web of Science ®Google Scholar
• CarvalhoLAGarnerBADewTFazakerleyHParianteCMAntidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanismsEur Neuropsychopharmacol201020637938720231081
   PubMed Web of Science ®Google Scholar
• HuJXiaYWuZLiuLTangCFluoxetine might alleviate brain damage and hypercortisolemia related to chronic alcohol in ratsJ Stud Alcohol Drugs201071229029420230727
   PubMed Web of Science ®Google Scholar
• OberlanderTFWeinbergJPapsdorfMGrunauRMisriSDevlinAMPrenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responsesEpigenetics2008329710618536531
   PubMed Web of Science ®Google Scholar
• FischliSJenniSAllemannSDehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axisJ Clin Endocrinol Metab200893253954217986637
   PubMed Web of Science ®Google Scholar
• SchuleCBaghaiTCEserDSchwarzMBondyBRupprechtREffects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patientsJ Psychiatr Res200943553854518706658
   PubMed Web of Science ®Google Scholar
• PaslakisGLuppaPGillesMVenlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatmentJ Psychiatr Res201044855656020022345
   PubMed Web of Science ®Google Scholar
• BinderEBKunzelHENickelTHPA-axis regulation at inpatient admission is associated with antidepressant therapy outcome in male but not in female depressed patientsPsychoneuroendocrinology20093419910918829172
   PubMed Web of Science ®Google Scholar
• JuruenaMFParianteCMPapadopoulosASPoonLLightmanSCleareAJPrednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistanceBr J Psychiatry2009194434234919336786
   PubMed Web of Science ®Google Scholar
• HallamKTBeggDPOlverJSNormanTRAn investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteersHum Psychopharmacol200823212913718172907
   PubMed Web of Science ®Google Scholar
• AhrensTFrankhauserPLederbogenFDeuschleMEffect of single-dose sertraline on the hypothalamus-pituitary-adrenal system, autonomic nervous system, and platelet functionJ Clin Psychopharmacol200727660260618004127
   PubMed Web of Science ®Google Scholar
• HashiokaSKlegerisAMonjiAAntidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxideExp Neurol20072061334217481608
   PubMed Web of Science ®Google Scholar
• ObuchowiczEKowalskiJLabuzekKKrysiakRPendzichJHermanZSAmitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell culturesInt J Neuropsychopharmacol200691273515963243
   PubMed Web of Science ®Google Scholar
• VollmarPNesslerSKalluriSRHartungHPHemmerBThe antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokinesInt J Neuropsychopharmacol200912452553618922202
   PubMed Web of Science ®Google Scholar
• TalerMGil-AdILomnitskiLImmunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expressionEur Neuropsychopharmacol2007171277478017499975
   PubMed Web of Science ®Google Scholar
• XiaZDePierreJWNassbergerLTricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cellsImmunopharmacology199634127378880223
   PubMed Web of Science ®Google Scholar
• Szuster-CiesielskaATustanowska-StachuraASlotwinskaMMarmurowska-MichalowskaHKandefer-SzerszenMIn vitro immunoregulatory effects of antidepressants in healthy volunteersPol J Pharmacol200355335336214506314
   PubMedGoogle Scholar
• MaesMSongCLinAHNegative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretionNeuropsychopharmacology199920437037910088138
   PubMed Web of Science ®Google Scholar
• KuberaMLinAHKenisGBosmansEvan BockstaeleDMaesMAnti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratioJ Clin Psychopharmacol200121219920611270917
   PubMed Web of Science ®Google Scholar
• KimYKNaKSShinKHJungHYChoiSHKimJBCytokine imbalance in the pathophysiology of major depressive disorderProg Neuropsychopharmacol Biol Psychiatry20073151044105317433516
   PubMed Web of Science ®Google Scholar
• SutcigilLOktenliCMusabakUPro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapyClin Dev Immunol200720077639618317531
   PubMed Web of Science ®Google Scholar
• WalshHADayaSInfluence of the antidepressants desipramine and fluoxetine on tryptophan-2,3-dioxygenase in the presence of exogenous melatoninLife Sci19986226241724239651108
   PubMed Web of Science ®Google Scholar
• JanssenDGCaniatoRNVersterJCBauneBTA psychoneuroimmunological review on cytokines involved in antidepressant treatment responseHum Psychopharmacol201025320121520373471
   PubMed Web of Science ®Google Scholar
• MillanMJGobertALejeuneFThe novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathwaysJ Pharmacol Exp Ther2003306395496412750432
   PubMed Web of Science ®Google Scholar
• de BodinatCGuardiola-LemaitreBMocaerERenardPMunozCMillanMJAgomelatine, the first melatonergic antidepressant: discovery, characterization and developmentNat Rev Drug Discov20109862864220577266
   PubMed Web of Science ®Google Scholar
• HowlandRHCritical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adultsNeuropsychiatr Dis Treat2009556357619966905
   PubMed Web of Science ®Google Scholar
• MartinetLGuardiola-LemaitreBMocaerEEntrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependentPharmacol Biochem Behav19965447137188853194
   PubMed Web of Science ®Google Scholar
• VanROWeibelLOlivaresEMaccariSMocaerETurekFWMelatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulusAm J Physiol Regul Integr Comp Physiol20012805R1582159111294784
   PubMed Web of Science ®Google Scholar
• CajochenCKrauchiKMoriDGrawPWirz-JusticeAMelatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasisAm J Physiol19972724 Pt 2R118911969140019
   PubMed Web of Science ®Google Scholar
• KrauchiKCajochenCMoriDGrawPWirz-JusticeAEarly evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperatureAm J Physiol19972724 Pt 2R117811889140018
   PubMed Web of Science ®Google Scholar
• LlorcaPMThe antidepressant agomelatine improves the quality of life of depressed patients: implications for remissionJ Psychopharmacol201024Suppl 2212620663805
   PubMed Web of Science ®Google Scholar
• Quera-SalvaMALemoinePGuilleminaultCImpact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patientsHum Psychopharmacol201025322222920373473
   PubMed Web of Science ®Google Scholar
• KasperSHajakGWulffKEfficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertralineJ Clin Psychiatry201071210912020193645
   PubMed Web of Science ®Google Scholar
• OlieJPKasperSEfficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorderInt J Neuropsychopharmacol200710566167317477888
   PubMed Web of Science ®Google Scholar
• SerrettiAChiesaATreatment-emergent sexual dysfunction related to antidepressants: a meta-analysisJ Clin Psychopharmacol200929325926619440080
   PubMed Web of Science ®Google Scholar
• MontgomerySAKennedySHBurrowsGDLejoyeuxMHindmarchIAbsence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation studyInt Clin Psychopharmacol200419527128015289700
   PubMed Web of Science ®Google Scholar